The content on this site is intended for healthcare professionals only
During a press conference at the 2013 ASH Annual Meeting, Dr Alice Bertaina presents data from a recent study on stem cell transplantation.
Transplants of haploidentical, or half-matched, blood-forming stem cells may be an effective option for patients in need of a transplant without a fully matched donor; however, in the past, in comparison to transplant from a fully matched donor, this treatment has been associated with an increased risk of infection and disease recurrence. This study tested the effectiveness of manipulating in the lab these half-matched donor stem cells.
Non-TBI conditioning achieves positive results in MRD-negative CAYA B-ALL undergoing allogeneic HCT
Blinatumomab added to chemotherapy improves disease-free survival in newly diagnosed NCI standard risk paediatric B-ALL
Isatuximab plus lenalidomide and dexamethasone with bortezomib as a new standard of care for NDMM TI non-frail patients
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Use of bispecifics and CAR T cells in South America
Treating relapsed multiple myeloma outside of use of T-cell redirected therapies
Guiding transplant decisions in multiple myeloma with MRD
Choosing 1st line TKI Wisely in patients with CML
CAR-T - Choosing Wisely
